EPR Properties vs MiniMed Group Inc. Common Stock — how do they compare? EPR Properties trades at $54.74 (market cap $4.17B), while MiniMed Group Inc. Common Stock trades at $19.71 (market cap $5.57B). The key difference: MiniMed Group Inc. Common Stock is the larger of the two by market cap, and EPR Properties pays a 6.84% dividend while MiniMed Group Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold EPR Properties for 46 Days and MiniMed Group Inc. Common Stock for 1 Days on average.
| EPR | MMED | |
|---|---|---|
Market Cap | $4.17B | $5.57B |
Volume | 992,716 | 23,336,073 |
Sector | Real Estate | Health |
52-Week High | $64.32 | $23.84 |
52-Week Low | $48.71 | $10.80 |
Typical Hold Time | 46 Days | 1 Days |
Enterprise Value | $7.68B | $5.37B |
Dividend Yield | 6.84% | — |
Signals from Pluang's Aura AI — not financial advice
EPR Properties trades at $54.41, up 0.61% today, with a bearish technical signal but oversold oscillators suggesting potential reversal. The REIT reported strong profitability with a 37.66% net income margin and a 6.5% dividend yield, though Q1 2026 earnings missed expectations. Recent news highlights its appeal for income investors, with monthly dividends and diversification into theme parks and fitness.
Outlook is mixed: analyst consensus is a Buy with a $65.50 target, but technicals and a projected 2026 net income decline pose risks. The stock offers value at a P/E of 17.44 and high yield, yet investors face headwinds from rising Treasury yields and competitive pressures in the net lease REIT sector.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
EPR Properties is a REIT specializing in experiential real estate, including movie theaters and leisure destinations like ski resorts and water parks across the US and Canada.
Read more on EPR →MiniMed develops, manufactures, and markets diabetes-management technologies. Its products include insulin-delivery systems, continuous glucose monitors, smart insulin pens, and related software.
Read more on MMED →